4% tetrasodium EDTA decreases central venous access device complications in ICU

ORLANDO — ICU patients with a central venous access device had a smaller incidence rate of device-related complications with 4% tetrasodium ethylenediaminetetraacetic acid vs. control locking fluid, according to results presented here.In addition to being presented at the American Thoracic Society International Conference, these data were simultaneously published in JAMA.

Raccontata dahealio.com